2024
14 Natural killer cells have impaired cytotoxicity in advanced renal cell carcinoma
Moritz V, Xu W, Birch G, Meliki A, Bharadwaj M, Schindler N, Labaki C, Saliby R, Dinh K, Horst J, Sun M, Kashima S, Machaalani M, Lee G, Hurwitz M, McGregor B, Hirsch M, Shukla S, McDermott D, Signoretti S, Romee R, Choueiri T, Braun D. 14 Natural killer cells have impaired cytotoxicity in advanced renal cell carcinoma. The Oncologist 2024, 29: s7-s8. PMCID: PMC11301877, DOI: 10.1093/oncolo/oyae181.012.Peer-Reviewed Original ResearchNK cell phenotypeGene expression signaturesNK cell populationK562 target cellsNK cellsRenal cell carcinomaAdvanced ccRCCNK cell clustersLocalized ccRCCAnti-tumor activityNormal kidneyNatural killerCell carcinomaMarkers of tissue residencyAdvanced renal cell carcinomaProportion of NK cellsFunction of NK cellsExpression of cytotoxic genesTarget cellsNK cell dysfunctionTotal immune cellsNK cell subsetsCell phenotypeCell populationsCell renal cell carcinoma
2021
Immune normalization strategy against suboptimal health status: safe and efficacious therapy using mixed-natural killer cells
Li Y, Harunori O, Fu S, Xing F, Wu H, Wang J, Chen A, Ren X, Peng D, Ling X, Shi M, Wu H. Immune normalization strategy against suboptimal health status: safe and efficacious therapy using mixed-natural killer cells. Aging 2021, 13: 20131-20148. PMID: 34461606, PMCID: PMC8436936, DOI: 10.18632/aging.203279.Peer-Reviewed Original ResearchMeSH KeywordsAdjuvants, ImmunologicAgedAntigensCD3 ComplexCD56 AntigenCD8-Positive T-LymphocytesCell Culture TechniquesHealth StatusHumansImmune SystemImmunityImmunotherapyKiller Cells, NaturalLeukocytes, MononuclearLymphomaMiddle AgedNeoplasmsPancreatic NeoplasmsProgrammed Cell Death 1 ReceptorReceptors, IgGT-Lymphocytes, Helper-InducerTreatment OutcomeConceptsPeripheral blood mononuclear cellsPD-1<sup>+</sup> T cellsProgrammed cell death protein 1Sub-healthy individualsNKM cellsImmune normalizationT cellsCD8<sup>+</sup>PD-1<sup>+</sup> T cellsCancer patientsCell death protein 1Proportion of NK cellsProportion of T helper cellsPeripheral immune systemT helper cellsBlood mononuclear cellsPotential clinical applicationsMalignant lymphomaNK cellsAdjuvant treatmentKiller cellsPancreatic cancerMononuclear cellsEfficacious therapyCancer preventionSide effects
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply